
    
      Background:

      -The National Cancer Institute Surgery Branch (NCI-SB) Branch investigator conducts clinical
      trials utilizing gene transfer. The current U.S. Food and Drug Administration (FDA)
      requirements for long term follow up may be up to fifteen years for some products. As this
      time period is frequently longer than studies are expected to be open, a long-term follow-up
      protocol is necessary to ensure the follow up of these subjects

      Objectives:

      -To facilitate collection of long term, follow up information on subjects who have
      participated in gene transfer studies as required by the U.S. Food and Drug Administration
      and other regulatory groups

      Eligibility:

      -Enrollment on a CAR T-cell treatment protocol for gene therapy.

      Design:

      -Patients will undergo physical exams; laboratory evaluation or phone follow up as required
      by the treatment protocol and/or as clinically indicated.
    
  